The historical rank and industry rank for Phase Holographic Imaging PHI AB's EV-to-FCF or its related term are showing as below:
FRA:L5W'
s EV-to-FCF Range Over the Past 10 Years
Min: -64.49 Med: -16.06 Max: 29.21
Current: -0.53
During the past 13 years, the highest EV-to-FCF of Phase Holographic Imaging PHI AB was 29.21. The lowest was -64.49. And the median was -16.06.
FRA:L5W's EV-to-FCF is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 23.355
vs FRA:L5W: -0.53
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phase Holographic Imaging PHI AB (FRA:L5W) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phase Holographic Imaging PHI AB's PE Ratio (TTM) for today is calculated as:
Phase Holographic Imaging PHI AB's share price for today is €0.0436.
Phase Holographic Imaging PHI AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.038.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Phase Holographic Imaging PHI AB EV-to-FCF Related Terms
Phase Holographic Imaging PHI AB EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phase Holographic Imaging PHI AB EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Phase Holographic Imaging PHI AB's EV-to-FCF falls into.
Phase Holographic Imaging PHI AB's current Enterprise Value is €1.58 Mil.
Phase Holographic Imaging PHI AB's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB (FRA:L5W) has a EV-to-FCF of -0.45 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Phase Holographic Imaging PHI AB and its competitors.
Is Phase Holographic Imaging PHI AB's EV-to-FCF too high?
Phase Holographic Imaging PHI AB's current EV-to-FCF is -0.45.
How does Phase Holographic Imaging PHI AB's EV-to-FCF compare to ABT and BSX?
Phase Holographic Imaging PHI AB's EV-to-FCF of -0.45 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-FCF is 23.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current EV-to-FCF is -0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current EV-to-FCF of -0.45. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current EV-to-FCF is -0.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current EV-to-FCF is -0.45 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phase Holographic Imaging PHI AB Business Description
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L5W has been successfully added to your 